Voyager Therapeutics - 4 Year Stock Price History | VYGR

Historical daily share price chart and data for Voyager Therapeutics since 2015 adjusted for splits. The latest closing stock price for Voyager Therapeutics as of May 17, 2019 is 22.15.
  • The all-time high Voyager Therapeutics stock price is 31.31, which is 41.4% above the current share price.
  • The Voyager Therapeutics 52-week high stock price is 24.49, which is 10.6% above the current share price.
  • The Voyager Therapeutics 52-week low stock price is 8.00, which is 63.9% below the current share price.
  • The average Voyager Therapeutics stock price for the last 52 weeks is 16.64.
Voyager Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 16.1183 9.4200 24.4900 8.0000 22.1500 135.64%
2018 18.3287 17.6300 31.3100 8.5900 9.4000 -43.37%
2017 12.6593 11.9700 25.8800 8.2400 16.6000 30.30%
2016 12.5015 21.1500 21.1500 8.5600 12.7400 -41.83%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.816B $0.008B
Voyager Therapeutics, Inc. is a gene therapy company. It focuses on the development of treatments for patients suffering from severe diseases of the central nervous system. Its pipeline includes VY-AADC01, which is in Phase 1b clinical trials for treatment of Parkinson's disease and preclinical programs comprise VY-SOD101 for a monogenic form of amyotrophic lateral sclerosis, VY-FXN01 for Friedreich ataxia and VY-HTT01 for Huntington's disease as well as VY-SMN101 for neuromuscular disease. Voyager Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $45.958B 8.37
Teva Pharmaceutical Industries (TEVA) Israel $11.826B 4.63
Mylan (MYL) United Kingdom $10.123B 4.42
Bausch Health Cos (BHC) Canada $8.818B 6.02
Dr Reddy's Laboratories (RDY) India $6.539B 24.46
Supernus Pharmaceuticals (SUPN) United States $1.742B 17.41
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.230B 1.84
Amphastar Pharmaceuticals (AMPH) United States $1.032B 57.68
Homology Medicines (FIXX) United States $0.977B 0.00
CymaBay Therapeutics (CBAY) United States $0.867B 0.00
Akorn (AKRX) United States $0.527B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.393B 0.00
Assembly Biosciences (ASMB) United States $0.389B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.326B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.158B 0.00
Sol-Gel Technologies (SLGL) Israel $0.157B 0.00
Acasti Pharma (ACST) Canada $0.067B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.063B 0.00
Agile Therapeutics (AGRX) United States $0.062B 0.00
Teligent (TLGT) United States $0.046B 0.00
Evoke Pharma (EVOK) United States $0.014B 0.00
Aevi Genomic Medicine (GNMX) United States $0.013B 0.00